Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 553 insiders at 344 companies
- $9.7B sold by 664 insiders outside a trading plan
- $4.6B sold by 964 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
J W Marriott Jr. 10% ownerMARMarriott International, Inc.Sale$1.2M 3,500 shares at $352.09 1.2% of stakeTraded Sep 25 Filed Sep 29
-
Dominic Piscitelli CFOORICOric Pharmaceuticals, Inc.Planned sale$181K 13,400 shares at $13.53 16% of stakeTraded Sep 28 Filed Sep 29
-
Jayshree Ullal CEOANETArista Networks, Inc.Planned sale$13.2M 62,622 shares at $211.40 0.4% of stakeTraded Sep 25 Filed Sep 29
-
Adam Eltoukhy See RemarksIOTSamsara Inc.Planned sale$285K 7,306 shares at $39.07 1.9% of stakeTraded Sep 25 Filed Sep 29
-
Mollie Leoni Chief Medical OfficerKURAKura Oncology, Inc.Planned sale$310K 28,802 shares at $10.75 17% of stakeTraded Sep 29 Filed Sep 29
-
Brian T. Powl Chief Commercial OfficerKURAKura Oncology, Inc.Planned sale$250K 23,430 shares at $10.69 15% of stakeTraded Sep 28–29 Filed Sep 29
-
Kurtis Joseph Binder CFOARLOArlo Technologies, Inc.Planned sale$168K 13,358 shares at $12.58 3.7% of stakeTraded Sep 29 Filed Sep 29
-
Julie M. Williams SVP/Cont. Improvement and Opt.SWXSouthwest Gas Holdings, Inc.Sale$205K 2,500 shares at $81.81 8.6% of stakeTraded Sep 28 Filed Sep 29
-
Jeffrey R. Leitzell COOEOGEOG Resources, Inc.Planned sale$1.3M 9,039 shares at $140.61 9.1% of stakeTraded Sep 25 Filed Sep 29
-
Jeff Cislini SVP & General CounselRVMDRevolution Medicines, Inc.Planned sale$159K 765 shares at $207.32 1.5% of stakeTraded Sep 25 Filed Sep 29
-
Robert Thomas Dechant CEOIBEXIBEX LimitedPlanned sale$225K 5,000 shares at $45.02 1.9% of stakeTraded Sep 25 Filed Sep 29
-
Ajit Jain Vice ChairmanBRK.ABerkshire Hathaway Inc.Sale$20M 39,700 shares at $503.09 37% of stakeTraded Sep 28 Filed Sep 29
-
Anton Reingold See RemarksGDEVGDEV Inc.Sale$201K 18,209 shares at $11.03 4.7% of stakeTraded Sep 28 Filed Sep 29
-
3D Investment Partners Pte. Ltd. Insider · +1 joint filerMNOVMediciNova, Inc.Sale$1.7M 640,000 shares at $2.70 12% of stakeTraded Sep 25 Filed Sep 29
-
Kevin McCulloch See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$250K 25,000 shares at $10.00 1.5% of stakeTraded Sep 28 Filed Sep 29
-
Pradheepa Raman Chief People OfficerGFSGlobalFoundries Inc.Planned sale$105K 2,145 shares at $48.83 100% of stakeTraded Sep 28 Filed Sep 29
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.6M 9,500 shares at $480.85 2.8% of stakeTraded Sep 28 Filed Sep 29
-
Yat Tung Lam COOCRDOCredo Technology Group Holding LtdPlanned sale$20.6M 100,000 shares at $206.29Traded Sep 25 Filed Sep 29
-
John Colgrove Chief Visionary OfficerPEverpure, Inc.Planned sale$12.5M 100,000 shares at $124.63 100% of stakeTraded Sep 25 Filed Sep 29
-
Thomas Edward Schoenherr CEO, DiagnosticsTEMTempus AI, Inc.Planned sale$874K 10,281 shares at $85.00 12% of stakeTraded Sep 25 Filed Sep 29
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$1.6M 2,564 shares at $620.10 0.7% of stakeTraded Sep 25–28 Filed Sep 29
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.4M 12,100 shares at $113.56 <0.1% of stakeTraded Sep 25 Filed Sep 29
-
Nicole Damato Chief Legal OfficerINNVInnovAge Holding Corp.Planned sale$207K 23,814 shares at $8.70 7.2% of stakeTraded Sep 25 Filed Sep 29
-
Ross Dove CEOHGBLHeritage Global Inc.Sale$399K 300,000 shares at $1.33 13% of stakeTraded Sep 25 Filed Sep 29
-
Ian Isaacs DirectorGLREGreenlight Reinsurance, Ltd.Sale$226K 15,150 shares at $14.93 29% of stakeTraded Sep 25–28 Filed Sep 29
-
Javier Hinojosa Senior Vice President of PowerBKVBKV CorporationPlanned sale$168K 7,428 shares at $22.66 8.8% of stakeTraded Sep 25 Filed Sep 29
-
John P/oh McConnell 10% ownerWORWorthington Enterprises, Inc.Sale$2.6M 42,491 shares at $60.43 3.1% of stakeTraded Sep 28 Filed Sep 29
-
Yanjun Wang CCO and GCSESea LimitedPlanned sale$219K 2,200 shares at $99.41 2.3% of stakeTraded Sep 25–28 Filed Sep 29
-
Yongdong Peng CEOBEKEKE Holdings IncSale$84.6M 16M shares at $5.27 20% of stakeTraded Sep 25 Filed Sep 29
-
Chandler Robinson CEOMNPRMonopar Therapeutics Inc.Planned sale$2.6M 29,056 shares at $88.00 23% of stakeTraded Sep 24 Filed Sep 28
-
Kang Jyh Lee DirectorPLABPhotronics, Inc.Sale$221K 7,500 shares at $29.50 2.1% of stakeTraded Sep 24 Filed Sep 28
-
Blackstone Holdings I L.P. 10% owner · +4 joint filersAPCARKO Petroleum Corp.Sale$2.1M 125,000 shares at $16.40 100% of stakeTraded Sep 24–25 Filed Sep 28
-
Steven B. Binder DirectorMNKDMannKind CorporationPlanned sale$128K 39,051 shares at $3.29 5.2% of stakeTraded Sep 25 Filed Sep 28
-
Kevin Rubin CFOZSZscaler, Inc.Planned sale$102K 519 shares at $197.28 1.2% of stakeTraded Sep 25 Filed Sep 28
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.2M 20,000 shares at $258.12 0.3% of stakeTraded Sep 24–25 Filed Sep 28
-
Mark Zuckerberg CEOMETAMeta Platforms, Inc., Class APlanned sale$21.4M 27,474 shares at $777.44 2.2% of stakeTraded Sep 24 Filed Sep 28
-
Sivaprasad Padisetty Chief Technology OfficerGTLBGitLab Inc.Planned sale$2.4M 51,915 shares at $45.78 12% of stakeTraded Sep 28 Filed Sep 28
-
Karen Boone DirectorSONOSonos, Inc.Planned sale$848K 46,766 shares at $18.13 40% of stakeTraded Sep 25 Filed Sep 28
-
Mayo A Shattuck III DirectorHUTHut 8 Corp.Planned sale$2M 20,000 shares at $100.00 18% of stakeTraded Sep 24 Filed Sep 28
-
Sytse Sijbrandij DirectorGTLBGitLab Inc.Planned sale$101M 2,116,200 shares at $47.77 14% of stakeTraded Sep 24–28 Filed Sep 28
-
Tomas Navratil Chief Development OfficerGKOSGlaukos CorporationPlanned sale$249K 1,615 shares at $154.28 2.2% of stakeTraded Sep 25 Filed Sep 28
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.4M 18,000 shares at $75.56 1.3% of stakeTraded Sep 24–28 Filed Sep 28
-
Anthony Mancini See RemarksRVMDRevolution Medicines, Inc.Planned sale$743K 3,708 shares at $200.45 8.5% of stakeTraded Sep 24–25 Filed Sep 28
-
Bruce L. Claflin DirectorCIENCiena CorporationSale$1M 2,857 shares at $355.91 26% of stakeTraded Sep 24 Filed Sep 28
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6M 61,000 shares at $98.57 18% of stakeTraded Sep 25–28 Filed Sep 28
-
Robert I Blum CEOCYTKCytokinetics, IncorporatedPlanned sale$491K 7,500 shares at $65.46 2.6% of stakeTraded Sep 28 Filed Sep 28
-
Mani Sundaram EVP and GM SecurityAKAMAkamai Technologies, Inc.Planned sale$882K 7,022 shares at $125.62 32% of stakeTraded Sep 25 Filed Sep 28
-
Kim Salem-Jackson EVP, Chief Marketing OfficerAKAMAkamai Technologies, Inc.Planned sale$258K 2,013 shares at $128.00 3.4% of stakeTraded Sep 25 Filed Sep 28
-
John C Malone 10% ownerLLYVKLiberty Live Holdings, Inc.Sale$2.9M 29,593 shares at $98.16 0.9% of stakeTraded Sep 24 Filed Sep 28
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $476.17 2.8% of stakeTraded Sep 25 Filed Sep 28
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.